Immucell ICCC
NASDAQ ICCC
$10.25 -0.14 (-1.35%)
As of: Oct 23, 2026 · 3:21 PM EDT

Immucell (ICCC) Non Operating Investment Income (2017 - 2025)

Updated

Immucell (ICCC) recorded Non Operating Investment Income of -$62,319 in Q3 2025.

Analysis

Immucell (ICCC) Non Operating Investment Income (2017 - 2025) Analysis & Trends

For FY2023, Immucell reported Non Operating Investment Income of -$8,099.

  • Across earlier years, Non Operating Investment Income came in at $7,334 in FY2022.
  • The Q3 2025 figure is the lowest quarterly Non Operating Investment Income in data going back to Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Immucell 92.91 Mn 70.36 Mn 2.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -62,319.00
Jun 30, 2025 7,128.00
Mar 31, 2025 -4,865.00
Jun 30, 2024 -14,557.00
Jun 30, 2023 77.00
Mar 31, 2023 -8,243.00
Sep 30, 2018 700,000.00
Dec 31, 2017 -1,340.00
API Access

Immucell Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ICCC&period=max&api_key=YOUR_API_KEY